Medical Cannabis for Ehlers-Danlos Syndrome

EDS and Chronic Pain

• Ehlers-Danlos syndrome causes hypermobility, joint instability, and widespread chronic pain
• Hypermobile EDS primarily affects women in teens and twenties
• Standard analgesics are frequently inadequate or poorly tolerated in EDS
• Medical cannabis is self-reported as beneficial in EDS patient community surveys

EDS represents a significant unmet need in pain management — medical cannabis is increasingly assessed by UK specialist clinicians.

Access and Prescribing

• EDS patients can self-refer to UK medical cannabis clinics — no GP referral needed
• Documentation of diagnosis and treatment history strengthens the assessment
• Telehealth means even housebound patients can access specialist consultations
• EDS-experienced clinicians exist within several UK cannabis clinic networks

Finding a clinician experienced with EDS is worth the research, as connective tissue disorders require nuanced cannabinoid prescribing.